Trial Profile

Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety and Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin and Sulfonylurea or Metformin in T2 Diabetic Patients

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 03 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

31 Jul 2013 Planned end date changed from 1 Nov 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
10 Jul 2013 This trial has been discontinued in Hungary and has an unknown status in Germany and the USA because this information has not been verified recently in the ClinicalTrials.gov record (last verified June 2011).
13 May 2013 Status changed from unconfirmed to discontinued as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com